73 related articles for article (PubMed ID: 25490162)
1. Reasons for participating in the Valencian Community Colorectal Cancer Screening Programme by gender, age, and social class.
Molina-Barceló A; Salas-Trejo D; Peiró-Pérez R; Vanaclocha M; Pérez E; Castán S
Rev Esp Enferm Dig; 2014 Aug; 106(7):439-47. PubMed ID: 25490162
[TBL] [Abstract][Full Text] [Related]
2. To participate or not? Giving voice to gender and socio-economic differences in colorectal cancer screening programmes.
Molina-Barceló A; Salas Trejo D; Peiró-Pérez R; Málaga López A
Eur J Cancer Care (Engl); 2011 Sep; 20(5):669-78. PubMed ID: 21771129
[TBL] [Abstract][Full Text] [Related]
3. Informed participation in the Valencian Community Colorectal Cancer Screening Programme from a gender perspective.
Molina-Barceló A; Peiró-Pérez R; Vanaclocha M; Vallés G; Guaita L; Salas D
Gac Sanit; 2018; 32(1):72-76. PubMed ID: 27745772
[TBL] [Abstract][Full Text] [Related]
4. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
[TBL] [Abstract][Full Text] [Related]
5. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
6. Reasons for participation and non-participation in colorectal cancer screening.
Berg-Beckhoff G; Leppin A; Nielsen JB
Public Health; 2022 Apr; 205():83-89. PubMed ID: 35248951
[TBL] [Abstract][Full Text] [Related]
7. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
[TBL] [Abstract][Full Text] [Related]
8. [Gender-specific influences on incidence, screening, treatment, and outcome of colorectal cancer].
Grundmann RT; Meyer F
Zentralbl Chir; 2013 Aug; 138(4):434-41. PubMed ID: 23950079
[TBL] [Abstract][Full Text] [Related]
9. Reasons for non-compliance in colorectal cancer screening with fecal occult blood test.
Li T; Nakama H; Wei N
Eur J Med Res; 1998 Aug; 3(8):397-400. PubMed ID: 9707523
[TBL] [Abstract][Full Text] [Related]
10. Providers role in colonoscopy screening for colorectal cancer.
Ramdass P; Petraro P; Via C; Shahrokni A; Nawaz H
Am J Health Behav; 2014 Mar; 38(2):234-44. PubMed ID: 24629552
[TBL] [Abstract][Full Text] [Related]
11. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy.
Ferlitsch M; Reinhart K; Pramhas S; Wiener C; Gal O; Bannert C; Hassler M; Kozbial K; Dunkler D; Trauner M; Weiss W
JAMA; 2011 Sep; 306(12):1352-8. PubMed ID: 21954479
[TBL] [Abstract][Full Text] [Related]
12. Health insurance-related disparities in colorectal cancer screening in Virginia.
de Bosset V; Atashili J; Miller W; Pignone M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):834-7. PubMed ID: 18398024
[TBL] [Abstract][Full Text] [Related]
13. Self-reported colonoscopy screening in Austria.
Haidinger G; Waldhoer T; Vutuc C
Eur J Cancer Prev; 2008 Aug; 17(4):354-7. PubMed ID: 18562961
[TBL] [Abstract][Full Text] [Related]
14. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of French people using organised colorectal cancer screening. Analysis of the 2010 French Health, Healthcare and Insurance Survey.
Fon Sing M; Leuraud K; Duport N
Prev Med; 2013 Jul; 57(1):65-8. PubMed ID: 23541516
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing colorectal cancer screening in rural southern Taiwan.
Lin YH; Kao CC
Cancer Nurs; 2013; 36(4):284-91. PubMed ID: 22964866
[TBL] [Abstract][Full Text] [Related]
17. Exploring the decision to participate in the National Health Service Bowel Cancer Screening Programme.
Ekberg M; Callender M; Hamer H; Rogers S
Eur J Cancer Prev; 2014 Sep; 23(5):391-7. PubMed ID: 24418799
[TBL] [Abstract][Full Text] [Related]
18. Are there gender differences in colorectal cancer test use prevalence and correlates?
McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
[TBL] [Abstract][Full Text] [Related]
19. [Test and programme sensitivities of screening for colorectal cancer in Reggio Emilia].
Campari C; Sassatelli R; Paterlini L; Camellini L; Menozzi P; Cattani A
Epidemiol Prev; 2011; 35(2):118-24. PubMed ID: 21628755
[TBL] [Abstract][Full Text] [Related]
20. Social inequalities in a population based colorectal cancer screening programme in the Basque Country.
Hurtado JL; Bacigalupe A; Calvo M; Esnaola S; Mendizabal N; Portillo I; Idigoras I; Millán E; Arana-Arri E
BMC Public Health; 2015 Oct; 15():1021. PubMed ID: 26438240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
